BackDaily Target 2X Long MRNA ETF Overview

Daily Target 2X Long MRNA ETF Receivables

Daily Target 2X Long MRNA ETF's receivables is $28M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$28.43M
↓ 7.16% YoYΔ $-2.19M vs prior year quarter

Peer trimmed avg / median

Loading

Daily Target 2X Long MRNA ETF Receivables History

Loading

Daily Target 2X Long MRNA ETF vs. peers: Receivables Comparison

Loading

Daily Target 2X Long MRNA ETF Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Daily Target 2X Long MRNA ETF (MRNX) FAQ

As of the most recent data (June 2016), MRNX shows a receivables of $28M. That compares with $31M in the prior-year period — down 7.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRNX's receivables is now $28M (was $31M) — a 7.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Daily Target 2X Long MRNA ETF is outperforming or lagging.

Tracking MRNX's receivables over time shows whether Daily Target 2X Long MRNA ETF is scaling, shrinking, or reshaping that part of the business. The current reading is $28M That compares with $31M in the prior-year period — down 7.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Daily Target 2X Long MRNA ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $28M) with ownership activity and broader fundamentals.